We investigated the mechanism of heterogeneous nuclear ribonucleoprotein F (hnRNP F) renoprotective action in a type 2 diabetes (T2D) mouse model (db/db). Immortalized rat renal proximal tubular cells (IRPTCs) and kidneys from humans with T2D were also studied. The db/db mice developed hyperglycemia, oxidative stress, and nephropathy at age 20 weeks compared with their db/m littermates. These abnormalities, with the exception of hyperglycemia, were attenuated in db/db hnRNP F-transgenic (Tg) mice specifically overexpressing hnRNP F in their RPTCs. Sirtuin-1, Foxo3a, and catalase expression were significantly decreased in RPTCs from db/db mice and normalized in db/db hnRNP F-Tg mice. In vitro, hnRNP F overexpression stimulated Sirtuin-1 and Foxo3a with downregulation of acetylated p53 expression and prevented downregulation of Sirtuin-1 and Foxo3a expression in IRPTCs by high glucose plus palmitate. Transfection of Sirtuin-1 small interfering RNA prevented hnRNP F stimulation of Foxo3a and downregulation of acetylated p53 expression. hnRNP F stimulated Sirtuin-1 transcription via hnRNP F-responsive element in the Sirtuin-1 promoter. Human T2D kidneys exhibited more RPTC apoptosis and lower expression of hnRNP F, SIRTUIN-1, and FOXO3a than nondiabetic kidneys. Our results demonstrate that hnRNP F protects kidneys against oxidative stress and nephropathy via stimulation of Sirtuin-1 expression and signaling in diabetes.
We investigated the mechanism of heterogeneous nuclear ribonucleoprotein F (hnRNP F) renoprotective action in a type 2 diabetes (T2D) mouse model (db/db). Immortalized rat renal proximal tubular cells (IRPTCs) and kidneys from humans with T2D were also studied. The db/db mice developed hyperglycemia, oxidative stress, and nephropathy at age 20 weeks compared with their db/m littermates. These abnormalities, with the exception of hyperglycemia, were attenuated in db/db hnRNP F-transgenic (Tg) mice specifically overexpressing hnRNP F in their RPTCs. Sirtuin-1, Foxo3a, and catalase expression were significantly decreased in RPTCs from db/db mice and normalized in db/db hnRNP F-Tg mice. In vitro, hnRNP F overexpression stimulated Sirtuin-1 and Foxo3a with downregulation of acetylated p53 expression and prevented downregulation of Sirtuin-1 and Foxo3a expression in IRPTCs by high glucose plus palmitate. Transfection of Sirtuin-1 small interfering RNA prevented hnRNP F stimulation of Foxo3a and downregulation of acetylated p53 expression. hnRNP F stimulated Sirtuin-1 transcription via hnRNP F-responsive element in the Sirtuin-1 promoter. Human T2D kidneys exhibited more RPTC apoptosis and lower expression of hnRNP F, SIRTUIN-1, and FOXO3a than nondiabetic kidneys. Our results demonstrate that hnRNP F protects kidneys against oxidative stress and nephropathy via stimulation of Sirtuin-1 expression and signaling in diabetes.
Silent mating type information regulation 2 homolog 1 (Sirtuin-1 or NAD-dependent deacetylation sirtuin-1) is a member of the sirtuin family (Sirtuin 1-7) (1) and deacetylases proteins that contribute to cellular regulation of calorie restriction-related longevity. Sirtuin-1 activation protects multiple organs against oxidative stress, including the kidneys (2) (3) (4) (5) (6) . Thus, glomerular injury was prevented in transgenic (Tg) mice specifically overexpressing Sirtuin-1 in renal proximal tubules (RPTs), whereas RPT-specific deletion of Sirtuin-1 aggravated glomerular damage in diabetes (7) .
Hyperglycemia, hyperlipidemia, oxidative stress, and dysregulation of the renin-angiotensin system have been implicated in diabetic nephropathy progression. We reported previously that reactive oxygen species (ROS) generation mediates high glucose (HG) stimulation of angiotensinogen (Agt, the sole precursor of all angiotensins) expression in immortalized rat RPT cells (IRPTCs) in vitro (8, 9) , and hyperglycemia and Agt overexpression in RPTCs work in concert to induce hypertension, albuminuria, and RPTC apoptosis in diabetic Agt-Tg mice (10) . Conversely, RPTCselective catalase (Cat) overexpression attenuated ROS generation and Agt gene expression and curbed hypertension, tubulointerstitial fibrosis, and RPTC apoptosis in diabetic mice (11) (12) (13) (14) , demonstrating that oxidative stress and intrarenal renin-angiotensin system dysregulation play a crucial role in diabetic nephropathy progression.
We also reported that insulin inhibits HG-induced stimulation of Agt gene expression and IRPTC hypertrophy via a novel insulin-responsive element (IRE) in the rat Agt gene promoter that binds two nuclear proteins, heterogeneous nuclear ribonucleoprotein F (hnRNP F) and hnRNP K (15) (16) (17) . Consistently, Akita (a type 1 diabetes model)-Tg mice specifically overexpressing hnRNP F in their RPTCs exhibited lower systolic blood pressure (SBP) and reduced renal hypertrophy and Agt expression (18) . Finally, hnRNP F and hnRNP K mediated insulin inhibition of renal Agt expression in Akita mice, thereby preventing hypertension and kidney injury (19) . These observations indicate that hnRNP F/K may play an important role in kidney protection in diabetes, but their underlying mechanism of action remains incompletely understood.
The aim of the current study was to investigate the underlying mechanism of hnRNP F action on kidney protection in db/db mice. 
RESEARCH DESIGN AND METHODS

Chemicals and Constructs
Generation of db/db hnRNP F-Tg Mice and Physiological Studies
Tg mice (C57Bl/6) overexpressing rat hnRNP F in RPTCs (line #937) were created in our laboratory (by J.S.D.C.) (18) , with a kidney-specific androgen-regulated protein promoter responsive to testosterone (21) . We cross-bred lean male db/m mice (C57BLKS) with female homozygous hnRNP F-Tg (C57Bl/6) mice, generating female db/m heterozygous hnRNP F-Tg mice, then backcrossed them with male db/m (C57BLKS) for at least 8 generations to obtain db/db homozygous hnRNP F-Tg mice (.95% in C57BLKS). Male db/db and db/db hnRNP F-Tg mice were tested at age 10 weeks. Age-and sex-matched db/m littermates served as controls. All animals received standard mouse chow and water ad libitum. Animal care and procedures were approved by the Centre de recherche, Centre hospitalier de l'Université de Montréal (CRCHUM) Animal Care Committee and followed the Principles of Laboratory Animal Care (National Institutes of Health Publication No. 85-23, revised 1985; http://grants1.nih.gov/grants/olaw/references/ phspol.htm).
Blood glucose levels were measured by Accu-Chek Performa (Roche Diagnostics, Laval, QC, Canada) after 4 to 5 h of fasting. SBP was monitored in the morning with BP-2000 tail-cuff (Visitech Systems, Apex, NC), at least 2-3 times per week per animal, for 10 weeks (18, 19, 22) . The mice were acclimatized to the procedure for at least 15-20 min per day for 5-7 days before the first SBP measurements.
All animals were housed individually in metabolic cages for 8 h during daytime before euthanasia at age 20 weeks. Body weight (BW) was recorded. Urine samples were collected and assayed for albumin and creatinine using the Albuwell and Creatinine Companion ELISA kits (Exocell, Inc., Philadelphia, PA). Immediately after euthanasia, the kidneys were removed, decapsulated, and weighed. Left kidneys were processed for histology and immunostaining and right kidneys for RPT isolation by Percoll gradient (18, 19, 22) .
The glomerular filtration rate (GFR) was estimated with fluorescein isothiocyanate inulin, as recommended by the Animal Models of Diabetic Complications Consortium (http://www.diacomp.org/), with slight modifications (18, 19, 22) .
Mouse urinary Agt, angiotensin II (Ang II), and Ang 1-7 levels were analyzed by ELISA (Immuno-Biological Laboratories, IBL America, Minneapolis, MN) and normalized by urinary creatinine levels (18, 19, 22) .
Caspase-3 (Csp3) activity was assayed in frozen (280°C) RPTs with Csp3 assay kits (BD Bioscience Pharmingen, Mississauga, ON, Canada) (23) (24) (25) .
Immunohistochemical Staining
Immunohistochemical staining was undertaken according to the standard avidin-biotin-peroxidase complex method in four to five sections (4 mm thick) per kidney and six mouse kidneys per group (ABC Staining System; Santa Cruz Biotechnology). Staining was analyzed under light microscopy by two independent, blinded observers. Images were assessed by ImageJ software (National Institutes of Health, http://rsb.info.nih.gov/ij/) (22) (23) (24) (25) .
Tubular luminal area and mean glomerular and RPTC volumes were assessed, as described elsewhere (22) (23) (24) (25) .
Cell Culture
Rat IRPTCs (passages 13 through 18) were studied (26) . Plasmids pcDNA 3.1 and pcDNA 3.1 containing rat hnRNP F cDNA were stably transfected into RPTCs (18) . To study the effects of HG and free fatty acids (sodium palmitate), stable transformants at 75-85% confluency were synchronized overnight in serum-free DMEM containing 5 mmol/L D-glucose, then cultured in various concentrations of D-glucose or palmitate for various periods up to 24 h. In separate experiments, IRPTCs and IRPTC-pcDNA 3.1/hnRNP F were cultured in serum-free medium containing 5 mmol/L D-glucose plus 30 mmol/L D-mannitol (NG) or 35 mmol/L D-glucose (HG) DMEM in the absence or presence of 200 mmol/L palmitate-bound BSA for 24 h (27).
Real-time Quantitative PCR
The mRNA levels of various genes in RPTs were quantified by real-time quantitative (q)PCR with the forward and reverse primers listed in Supplementary Table 2 (22) (23) (24) (25) .
Western Blotting
Western blotting (WB) was performed, as required (22) (23) (24) (25) . Relative densities of hnRNP F, Cat, Nox4, Agt, ACE, Ace2, MasR, active Csp3 (A-Csp3), Bax, Bcl-2, Sirtuin-1, Foxo3a, Ac-p53, and b-actin bands were quantified by computerized laser densitometry using ImageQuant 5.1 software (Molecular Dynamics, Sunnyvale, CA).
Immunostaining of Kidney Biopsy Samples From Patients With and Without Diabetes
Eight kidney biopsy samples (paraffin sections) for immunostaining were obtained from the Centre hospitalier de l'Université de Montréal (CHUM) Department of Pathology. This study was approved by the CHUM Clinical Research Ethics Committee. All patients gave informed consent.
Statistical Analysis
Data are expressed as means 6 SEM. Statistical analysis was performed with the Student t test or one-way ANOVA and the Bonferroni test, as appropriate, provided by GraphPad Prism 5.0 software (http://www.graphpad.com/prism/Prism. htm). P , 0.05 values were considered to be statistically significant.
RESULTS
RPTC-Specific Expression of hnRNP F Transgene in db/db Tg Mouse Kidneys
We confirmed the presence of hnRNP F-HA transgene in isolated RPTs from db/m hnRNP F-Tg and db/db hnRNP F-Tg mice but not in db/m and db/db mice ( Fig. 1A ). Wild-type (WT) leptin receptor (LepR) was expressed in RPTs of db/m and db/m hnRNP F-Tg mice but not in RPTs of db/db and db/db hnRNP F-Tg animals ( Fig. 1A) . Mutant LepR was detected in all groups (Fig. 1A) . hnRNP F mRNA expression levels were markedly higher in RPTs from db/m hnRNP F-Tg and db/db hnRNP F-Tg mice than in db/m and db/db mice, respectively ( Fig. 1B) , consistent with changes in hnRNP F immunostaining ( Fig. 1C ) and WB ( Fig. 1D ). hnRNP F overexpression was RPTC-specific because it colocalized with aquaporin-1 (AQP1), a marker of RPTCs ( Fig.  1E ). Furthermore, hnRNP F overexpression normalized SBP in db/db hnRNP F-Tg mice ( Fig. 1F ).
Physiological Parameters in db/db and db/db hnRNP F-Tg Mice at Age 20 Weeks Blood glucose levels were significantly higher in db/db than in db/m and db/m hnRNP F-Tg mice ( Supplementary Table  3 ). hnRNP F overexpression in RPTCs did not affect blood glucose levels in db/db hnRNP F-Tg mice. SBP, BW, kidney weight, kidney weight-to-tibial length ratio, GFR, and albumin-to-creatinine ratio were all elevated in db/db compared with db/m or db/m hnRNP F-Tg mice. hnRNP F overexpression in RPTCs attenuated these changes, except for BW and GFR-to-BW, in diabetic db/db hnRNP F-Tg mice. Urinary Agt and Ang I levels were elevated in db/db mice, parallel with decreased Ang 1-7 levels compared with db/m mice. hnRNP F overexpression in db/db mice partially reduced urinary Agt and Ang II levels, whereas it completely normalized urinary Ang 1-7 levels.
hnRNP F Overexpression Attenuates Oxidative Stress in db/db Mouse Kidneys
The db/db mice exhibited significantly more pronounced dihydroethidium (DHE) staining ( Fig. 2A) 
hnRNP F Overexpression Attenuates Tubulointerstitial Fibrosis and Profibrotic Gene Expression in db/db Mouse Kidneys
Periodic acid-Schiff staining (Fig. 3A ) revealed enhanced extracellular matrix protein expression, tubular lumen dilation, and cell debris accumulation. Some RPTCs were flattened in db/db compared with db/m and db/m hnRNP F-Tg mice. hnRNP F overexpression in db/db hnRNP F-Tg mice markedly suppressed, although never completely prevented, these abnormalities (Fig. 3A) . Glomerular tufts and RPTC volume were significantly higher in db/db than in db/m and db/m hnRNP F-Tg mice ( Supplementary Table 3 ). hnRNP F overexpression partially reduced glomerular tuft volume and almost completely normalized RPTC volume in db/db hnRNP F-Tg mice.
Kidneys from db/db mice exhibited significantly higher levels of collagenous components (Masson's trichrome staining), transforming growth factor (TGF)-b1, fibronectin 1 (FN1), and collagen 1 (Col I) expression ( Fig. 3B -E, respectively) relative to db/m and db/m hnRNP F-Tg mice. hnRNP F overexpression markedly reduced tubulointerstitial fibrosis in db/db mice ( Fig. 3B-E ). Quantitative analysis of Masson's trichrome staining (Fig. 3F) and qPCR quantitation of TGF-b1, FN1, and Col I ( Fig. 3G -I, respectively) mRNA expression confirmed these findings. 
hnRNP F Overexpression Prevents Tubular Apoptosis in db/db Mouse Kidneys
Next, we investigated the effect of hnRNP F overexpression on tubular apoptosis in db/db mice. The number of TUNELpositive nuclei in RPTCs from db/db mice was significantly higher than in db/m and db/m hnRNP F-Tg mice (Fig. 4A ). hnRNP F overexpression significantly reduced the number of TUNEL-positive cells. Consistently, immunostaining for B-cell lymphoma 2 (Bcl-2)-associated protein X (Bax) (Fig.  4B ) and A-Csp3 or cleaved Csp3 (Fig. 4C ) was significantly stronger in db/db versus db/m and db/m hnRNP F-Tg mice. hnRNP F overexpression also attenuated Bax and A-Csp3 expression ( Fig. 4B and C) . Assessment of TUNEL-positive cells (Fig. 4D ) and A-Csp3 activity (Fig. 4E ) in isolated RPTs confirmed these findings. Furthermore, Bax/Bcl-2 mRNA expression was higher in db/db than in db/m and db/m hnRNP F-Tg mice and was reversed in db/db hnRNP F-Tg mice (Fig. 4F ). WB of A-Csp3, Bax, and Bcl-2 ( Fig. 4G -I, respectively) confirmed these findings.
hnRNP F Overexpression Stimulates Sirtuin-1 and Foxo3a and Inhibits Acetylated p53 Expression in db/db Mouse Kidneys
To investigate the mechanism of hnRNP F action on tubulointerstitial fibrosis and apoptosis in db/db mice, we explored the expression of Sirtuin-1 and its downstream target proteins, Foxo3a and acetylated (Ac)-p53. Sirtuin-1 and Foxo3a expression was significantly decreased in RPTCs of db/db compared with db/m and db/m hnRNP F-Tg mice ( Fig. 5A and B) . hnRNP F overexpression increased Sirtuin-1 and Foxo3a immunostaining in RPTCs from db/m hnRNP F-Tg and db/db hnRNP F-Tg compared with db/m and db/db mice. In contrast, Ac-p53 immunostaining was stronger in RPTCs from db/db versus db/m and db/m hnRNP F-Tg mice (Fig. 5C ). hnRNP F overexpression attenuated Ac-p53 expression in RPTCs. Quantitation of Sirtuin-1, Foxo3a, and Ac-p53 ( Fig. 5D -F, respectively) expression by WB confirmed these findings. hnRNP F overexpression stimulated Sirtuin-1 mRNA expression in db/m hnRNP F-Tg and db/db hnRNP F-Tg compared with db/m and db/db mice, respectively (Fig. 5G ). No differences were detected in Foxo3a and p53 mRNA expression ( Fig.  5H and I) .
hnRNP F Overexpression Stimulates Sirtuin-1 and Prevents Downregulation of Sirtuin-1 Expression by HG and Palmitate in Rat IRPTCs In Vitro
To validate our findings in vivo, IRPTCs were stably transfected with hnRNP F cDNA and cultured in NG medium. IRPTCs stably transfected with pcDNA 3.1/hnRNP F (designated as IRPTC-pcDNA 3.1/hnRNP F) exhibited considerably higher levels of hnRNP F (Fig. 6Ai and Bi), Sirtuin-1 ( Fig. 6Aii and Bii), and Foxo3a ( Fig. 6Aiii and Biii), but lower levels of Ac-p53 ( Fig. 6Aiv and Biv) compared with nontransfected IRPTCs or IRPTCs stably transfected with pcDNA 3.1 (designated as IRPTC-pcDNA 3.1). Real-time qPCR of hnRNP F, Sirtuin-1, Foxo3a, and p53 mRNA levels revealed that hnRNP F overexpression stimulated Sirtuin-1 but not Foxo3a and p53 mRNA expression compared with nontransfected IRPTCs and IRPTC-pcDNA 3.1 (Supplementary Fig. 1 ).
Next, we investigated whether knockdown of Sirtuin-1 could prevent hnRNP F effect on Foxo3a and Ac-p53 expression. Transfection with Sirtuin-1 siRNA had no effect on hnRNP F expression ( Fig. 6Ci and Di) but reduced endogenous Sirtuin-1 protein expression, whereas scrambled siRNA had no effect (Fig. 6Cii and Dii and Supplementary  Fig. 2A ). Transfection with Sirtuin-1 siRNA attenuated hnRNP F stimulation of Foxo3a ( Fig. 6Ciii and Diii) and hnRNP F inhibition of Ac-p53 ( Fig. 6Civ and Div) expression in IRPTC-pcDNA 3.1/hnRNP F.
To explore whether HG and free fatty acids affect Sirtuin-1 expression, IRPTCs were cultured in the absence or presence of D-glucose or palmitate or a combination of HG and palmitate. D-glucose and palmitate alone inhibited Sirtuin-1 expression in a concentration-dependent manner ( Supplementary Fig. 2B and C) , and their combination was more effective in suppressing Sirtuin-1 expression in nontransfected IRPTCs ( Supplementary Fig. 2D ). HG and palmitate were also effective in inhibiting hnRNP F ( Fig. 6Ei and Fi), Sirtuin-1 (Fig. 6Eii and Fii), and Foxo3a ( Fig. 6Eiii and Fiii) expression and augmenting Ac-p53 ( Fig.  6Eiv and Fiv) expression in IRPTC-pcDNA 3.1, but these changes were prevented in IRPTC-pcDNA 3.1/hnRNP F.
hnRNP F-RE Localization in Rat Sirtuin-1 Gene Promoter
To localize putative hnRNP F-RE that mediates the action of hnRNP F on Sirtuin-1 gene promoter activity, pGL4.20 plasmid containing various lengths of the rat Sirtuin-1 promoter were transiently transfected into IRPTC-pcDNA 3.1 or IRPTC-pcDNA 3.1/HnRNP F and cultured in NG medium. pGL4.20-Sirtuin-1 promoter (N-1,381/+84) and pGL4.20-Sirtuin-1 promoter (N-1,036/+84) activity respectively exhibited 1.5-fold and 2.5-fold increases compared with control plasmid pGL4.20 in IRPTC-pcDNA 3.1 (Fig.  7A ). Deletion of nucleotides N-1,036 to N-415 or N-201 (pGL4.20-Sirtuin-1 promoter [N-415/+84] and pGL4.20-Sirtuin-1 promoter [N-201/+84], respectively) reduced the Sirtuin-1 promoter activity to baseline as pGL4.20 vector. Interestingly, pGL4.20-Sirtuin-1 promoter (N-1,381/+84) and pGL4.20-Sirtuin-1 promoter (N-1,036/+84) activity was further increased by 1.5-to 2.0-fold in IRPTC-pcDNA 3.1/hnRNP F, whereas the promoter activity of other fusion genes did not increase in IRPTC-pcDNA 3.1/hnRNP F compared with IRPTC-pcDNA 3.1 (Fig. 7A ). HG plus palmitate inhibited pGL4.20-Sirtuin-1 promoter (N-1,381/+84) and pGL4.20-Sirtuin-1 promoter (N-1,036/+84) activity without affecting other fusion genes in IRPTC-pcDNA 3.1 (Fig. 7B) . Moreover, hnRNP F overexpression prevented the inhibitory effect of HG plus palmitate (Fig. 7C) .
Transient transfection of hnRNP F cDNA stimulated pGL4.20-Sirtuin-1 promoter (N-1,081/+84) and pGL4.20-Sirtuin-1 promoter (N-1,036/+84) activity by 1.5-to 2.0-fold, whereas deletion of nucleotides N-973 to N-962 (59-GGGGGTTGGGGA-39) in the Sirtuin-1 gene promoter prevented the stimulatory effect of hnRNP F (Fig. 7D) .
Electrophoretic mobility shift assay (EMSA) revealed that the double-strand DNA fragment nucleotides N-977 to N-958 (putative hnRNP F-RE) bind to nuclear proteins from IRPTCs, which can be displaced by respective WT DNA but not by mutated DNA fragments (Fig. 7Ei ). The addition of anti-hnRNP F antibody induced hnRNP F-RE supershift with nuclear proteins but not by rabbit IgG (Fig. 7Eii ).
AGT, hnRNP F, SIRTUIN-1, FOXO3a, and Ac-p53 Expression in Diabetic Human Kidneys
The clinical characteristics of eight patients (four without type 2 diabetes [T2D] and four with T2D) are summarized in Supplementary Tables 4 and 5 . All patients underwent nephrectomy due to kidney cancer. The number of TUNEL-positive nuclei in RPTCs from apparently healthy sections of nephrectomy specimens from patients with T2D was significantly higher than those in patients without T2D (Fig. 8A ). Immunohistochemical staining for AGT and Ac-p53 was higher in diabetic than in nondiabetic human kidneys ( Fig. 8B and C and Supplementary Fig. 4B and C) . Decreased immunostaining for hnRNP F, SIRTUIN-1, and FOXO3a was detected in RPTCs from patients with T2D compared with RPTCs from patients without T2D (Fig. 8D-F and Supplementary Fig. 4D-F) . These observations are consistent with the changes observed in RPTCs of db/db mice. 
DISCUSSION
The present report identifies a novel mechanism of hnRNP F action on kidney protection via stimulation of RPTC Sirtuin-1 gene transcription in diabetic db/db mice.
We reported previously that hnRNP F overexpression in RPTCs attenuates systemic hypertension and RPTC hypertrophy in Akita mice, inhibits RPTC Agt, and stimulates Ace2 transcription via binding to hnRNP F-RE in Agt and Ace2 promoters, respectively (15, 16, 19, 22) . Our present study shows a novel finding that hnRNP F stimulates Sirtuin-1 transcription via binding of hnRNP F to the hnRNP F-RE in the Sirtuin-1 promoter, which, in turn, augments Foxo3a and Cat, decreases Ac-p53 expression, and subsequently attenuates RPTC oxidative stress, tubulointerstitial fibrosis, and apoptosis in db/db mice.
hnRNP F, a member of the premRNA-binding protein family (28) , regulates gene expression at transcriptional and posttranscriptional levels. hnRNP F engages in alternative splicing of various genes (29, 30) and associates with TATAbinding protein, RNA polymerase II, nuclear cap-binding protein complex, and various transcription factors (31, 32) . The molecular mechanisms underlying hnRNP F regulation of gene transcription are still incompletely understood.
The db/db mouse (LepR db/db ) on a C57BLKS background (33, 34) is a useful animal model to investigate many features of T2D in humans, including albuminuria, kidney injury, obesity, blood glucose, insulin resistance, and b-cell failure.
Our data show that hnRNP F overexpression in RPTCs from db/db hnRNP F-Tg mice exhibited lower oxidative stress, SBP, and albuminuria compared with db/db mice. However, the underlying molecular mechanisms remain to be investigated. One possibility is that hnRNP F decreases intrarenal Ang II formation via inhibition of Agt expression and, therefore, prevents Ang II stimulation of NADPH oxidase activity, Nox4 expression, and oxidative stress. This possibility is supported by our previous observations (18, 22) and the current results that hnRNP F overexpression inhibited Agt and upregulated Ace2 and MasR expression in RPTCs from db/db hnRNP F-Tg mice ( Supplementary  Fig. 3 ) while lowering urinary Agt and Ang II and increasing urinary Ang 1-7. Thus, decreasing the intrarenal Ang II-to-Ang 1-7 ratio would lessen efferent constriction and subsequently reduce SBP and albuminuria. Another possibility is that hnRNP F stimulates Cat expression via enhanced Sirtuin-1 and Foxo3a expression, leading to decreased ROS generation (35) . Thus, reduction of oxidative stress would decrease Agt/Ang II expression and reduce SBP and urinary albumin secretion as well as inhibit RPTC apoptosis, as we previously reported (11) . This possibility is supported by elevated Foxo3a expression and increased Cat expression in db/db hnRNP F-Tg compared with db/db mice. Clearly, additional studies are needed to elucidate the molecular mechanisms by which hnRNP F reduced oxidative stress, SBP, and albuminuria in diabetes.
Our study clearly demonstrates that hnRNP F overexpression attenuates tubulointerstitial fibrosis and RPTC apoptosis in db/db mice. Although the molecular mechanisms of hnRNP F action have not been fully elucidated, reduced fibrosis and RPTC apoptosis can at least partly be explained by suppression of profibrotic and proapoptotic gene expression in RPTCs. Indeed, hnRNP F overexpression suppressed TGF-b1, FN1, and Col I expression and downregulated Bax and A-Csp3 expression in db/db hnRNP F-Tg compared with db/db mice. Furthermore, Sirtuin-1 and Foxo3a were suppressed and Ac-p53 expression was enhanced in the RPTCs of db/db mice and normalized by hnRNP F overexpression in db/db hnRNP F-Tg mice. These would indicate that the beneficial actions of hnRNP F in db/db mice are partly mediated via enhanced Sirtuin-1 expression, with subsequent increases in Foxo3a and decreases in Ac-p53 expression.
To demonstrate that hnRNP F can directly stimulate Sirtuin-1 expression and subsequently modulate its downstream targets, we stably overexpressed hnRNP F in IRPTCs. hnRNP F overexpression resulted in increased Sirtuin-1 mRNA and protein expression and elevated Foxo3a and downregulated Ac-p53 protein levels without affecting their mRNA expression. We also observed that knockdown of Sirtuin-1 by siRNA prevented hnRNP F stimulation of Foxo3a and inhibition of Ac-p53 expression in IRPTCs. These findings clearly indicate an involvement of Sirtuin-1 in mediating hnRNP F stimulation of Foxo3a and inhibition of Ac-p53 expression in diabetic mouse kidney. Furthermore, hnRNP F overexpression prevented HG plus palmitate-evoked changes of Sirtuin-1, Foxo3, and Ac-p53 expression. These findings would indicate that hnRNP F overexpression prevented not only HG-evoked oxidative stress but also palmitate-induced oxidative stress in RPTCs via stimulation of Sirtuin-1 expression with subsequent Cat upregulation and Nox4 downregulation. Finally, we found that knockdown with hnRNP F siRNA reduced Sirtuin-1 expression without affecting Foxo3a and p53 expression and increased Agt expression and oxidative stress but not cell proliferation or hnRNP K expression in IRPTCs in NG ( Supplementary Fig. 5 ). These data would link hnRNP F, oxidative stress, and Sirtuin-1 expression in RPTCs. Nevertheless, additional studies using RPTC-specific hnRNP F knockout mice are needed to firmly establish the action of hnRNP F.
The precise mechanism by which hnRNP F upregulates Sirtuin-1 expression remains unclear. One possibility is that hnRNP F binds to putative hnRNP F-RE in the Sirtuin-1 promoter, subsequently enhancing Sirtuin-1 transcription. Indeed, we found that hnRNP F overexpression considerably augmented Sirtuin-1 promoter activity and that deletion of putative hnRNP F-RE (N-973 to N-962; 59-GGGGGTTGGGGA-39) markedly reduced the Sirtuin-1 promoter activity in IRPTCs. Furthermore, biotinylated-labeled hnRNP F-RE specifically bound to IRPTC nuclear proteins, and the addition of anti-hnRNP F antibody yielded supershift of biotinylated-labeled hnRNP F-RE binding with
